Observational Study of Acalabrutinib in Patients with Chronic Lymphocytic Leukaemia in the United Kingdom

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Country	Location
United Kingdom	Aylesbury, United Kingdom
United Kingdom	Bath, United Kingdom
United Kingdom	Birmingham, United Kingdom
United Kingdom	Bournemouth, United Kingdom
United Kingdom	Cardiff, United Kingdom
United Kingdom	Conrnwall, United Kingdom
United Kingdom	Dartford, United Kingdom
United Kingdom	Derby, United Kingdom
United Kingdom	Doncaster, United Kingdom
United Kingdom	Dorset, United Kingdom
United Kingdom	Eastbourne, United Kingdom
United Kingdom	Hull, United Kingdom
United Kingdom	Lincoln, United Kingdom
United Kingdom	Liverpool, United Kingdom
United Kingdom	London, United Kingdom
United Kingdom	Mid Yorkshire, United Kingdom
United Kingdom	Middlesborough, United Kingdom
United Kingdom	Newcastle, United Kingdom
United Kingdom	North Shields, United Kingdom
United Kingdom	Norwich, United Kingdom
United Kingdom	Nottingham, United Kingdom
United Kingdom	Oxford, United Kingdom
United Kingdom	Plymouth, United Kingdom
United Kingdom	Southampton, United Kingdom
United Kingdom	Stockton on Tees, United Kingdom
United Kingdom	Stoke on Trent, United Kingdom
United Kingdom	Wigan, United Kingdom